Xeris Biopharma Holdings Inc (XERS)
Other Income/Expenses (Net)
-$53.76M
TTM · Period ending: · USD
XERS Other Income/Expenses (Net)
Latest reported-$53.76Mperiod ending
Latest reported-$53.76Mperiod ending
XERS TTM Other Income/Expenses (Net) ($75.00K → -$53.76M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
XERS other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -53,758,000 | |
| -23,894,000 | |
| -24,342,000 | |
| -25,442,000 | |
| -25,501,000 | |
| -25,160,000 | |
| -23,458,000 | |
| -20,451,000 | |
| -21,896,000 | |
| -20,365,000 | |
| -19,494,000 | |
| -13,807,000 | |
| -9,583,000 | |
| -12,653,000 | |
| -14,144,000 | |
| -18,565,000 | |
| -16,826,000 | |
| -10,946,000 | |
| -7,569,000 | |
| -7,564,000 | |
| -8,169,000 | |
| -8,445,000 | |
| -7,704,000 | |
| -5,929,000 | |
| -6,427,000 | |
| -4,748,000 | |
| -3,658,000 | |
| -3,024,000 | |
| -94,000 | |
| -399,000 | |
| -736,000 | |
| -568,000 | |
| -699,000 | |
| -102,000 | |
| 75,000 |